Keywords
Rheumatoid Arthritis
Lupus
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To analyze the prevalence of autoimmune rheumatic diseases in patients treated by primary health care of the Unified Health Service in a municipality west of Santa Catarina, their general characteristics, the therapy used, and the main comorbidities. Methods: This observational, cross-sectional study, based on electronic medical records, involved 223 patients undergoing treatment at a municipal rheumatic disease outpatient clinic in 2020. Results: The prevalent age group found was 51 to 60, with 86% women, p<0.01. Rheumatoid Arthritis was the most prevalent disease, followed by Lupus, Systemic Sclerosis, and Ankylosing Spondylitis p<0.0001. The most commonly used medications were methotrexate and prednisone, p<0.05. A more significant correlation was observed between Rheumatoid Arthritis and Arterial Hypertension, followed by Hypothyroidism, Depression, and Dyslipidemia, p<0.01. Methotrexate had the most critical unwanted effects (58.4%). Conclusion: The diseases Rheumatoid Arthritis, Lupus, Systemic Sclerosis, and Ankylosing Spondylitis were prevalent in this study. There is a demand for professional qualifications, management of adverse drug effects, and improvement of the health system in caring for patients.
References
ALIVERNINI S, et al. The pathogenesis of rheumatoid arthritis. Immunity. 2022; 55(12): 2255-2270.
AMARAL JM, et al. Cultural Adaptation and Validation of the Methotrexate Intolerance Severity Score in Brazilian Portuguese for Adults With Rheumatoid Arthritis. J Clin Rheumatol. 2021; 27(6): S168-S172.
ARAÚJO MARIA DANIELLY BENÍCIO DE. Prevalência de doenças autoimunes na Atenção Primária à Saúde. 2017. 66f. Monografia (Bacharelado em Enfermagem) - Centro de Formação de Professores, Universidade Federal de Campina Grande, Cajazeiras, Paraíba, Brasil, 2017.
ASANO YOSHIHIDE. The Pathogenesis of Systemic Sclerosis: An Understanding Based on a Common Pathologic Cascade across Multiple Organs and Additional Organ-Specific Pathologies. J Clin Med. 2020; 9(9): 2687.
BARALIAKOS X, et al. Efficiency of treatment with non-steroidal anti-inflammatory drugs according to current recommendations in patients with radiographic and non-radiographic axial spondyloarthritis. Rheumatology (Oxford). 2017; 56(1): 95-102.
BOND DEBORAH. Ankylosing spondylitis: diagnosis and management. Nurs Stand. 2013; 28(16-18): 52-9.
BORBA EF, et al. Consenso de lúpus eritematoso sistêmico. Rev Bras Reumatol. 2008J; 48(4): 196–207.
CAO F, et al. Temporal trends in the prevalence of autoimmune diseases from 1990 to 2019. Autoimmun Rev. 2023; 22(8): 103359.
CONRAD N, et al. Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK. Lancet. 2023; 401(10391): 1878-1890.
CORBACHO MI e DAPUETO JJ. Avaliação da capacidade funcional e da qualidade de vida de pacien-tes com artrite reumatoide. Revista Brasileira de Reumatologia. 2010; 50(1): 31–43.
DAMIAN L, et al. No definitive evidence for a connection between autoimmune thyroid diseases and stress in women. Neuro Endocrinol Lett. 2016; 37(3): 155-162.
DENTON CP e KHANNA D. Systemic sclerosis. Lancet. 2017; 390(10103): 1685-1699.
FANOURIAKIS A, et al. Update οn the diagnosis and management of systemic lupus erythematosus Annals of the Rheumatic Diseases 2021; 80: 14-25.
FINCKH A, et al. Global epidemiology of rheumatoid arthritis. Nat Rev Rheumatol. 2022; 18(10): 591-602.
HOCHBERG MC, et al. Reumatology, Filadelfia: Elselvier, 2018; 7.
MILLER FREDERICH W. The increasing prevalence of autoimmunity and autoimmune diseases: an ur-gent call to action for improved understanding, diagnosis, treatment, and prevention. Curr Opin Immu-nol. 2023; 80: 102266.
MOTA LMH, et al. Princípios gerais do tratamento da artrite reumatoide inicial. Rev Assoc Med Bras. 2010;56(3):360–2.
MOTA LMH, et al. Diretrizes para o diagnóstico da artrite reumatoide. Rev Bras Reumatol. 2013; 53(2): 141–57.
ORTONA E, et al. Sex-based differences in autoimmune diseases. Ann Ist Super Sanita. 2016; 52(2): 205-12.
PARKS CG, et al. Life Events, Caregiving, and Risk of Autoimmune Rheumatic Diseases in the Wom-en's Health Initiative Observational Study. Arthritis Care Res (Hoboken). 2023; 75(12): 2519-2528.
PEREIRA IA, et al. Recomendações nacionais baseadas em evidências científicas e opiniões dos es-pecialistas sobre o uso do metotrexato nas doenças reumáticas, especialmente na artrite reumatoide: resultados da iniciativa 3E do Brasil. Rev Bras Reumatol. 2009; 49(4): 346–61.
PEREIRA IA, et al. Consenso 2012 da Sociedade Brasileira de Reumatologia sobre o manejo de co-morbidades em pacientes com artrite reumatoide. Rev Bras Reumatol. 2012; 52(4): 483–95.
REIS MG e COSTA IP. Qualidade de vida relacionada à saúde em pacientes com lúpus eritematoso sistêmico no Centro-Oeste do Brasil. Rev Bras Reumatol [Internet]. 2010; 50(4): 408–14.
REIS NETO ET, et al. Revisiting hydroxychloroquine and chloroquine for patients with chronic immunity-mediated inflammatory rheumatic diseases. Adv Rheumatol. 2020; 60(1): 32.
ROCHA FAC, et al. Advances in rheumatology practice in Brazil. Rheumatol Int. 2019; 39(7): 1125-1134.
ROLIM ALK, et al. Avaliação epidemiológica de doenças autoimunes diagnosticadas e tratadas no am-bulatório da Policlínica Oswaldo Cruz, Município de Porto Velho, RO: Epidemiological evaluation of au-toimmune diseases diagnosed and treated at the Oswaldo Cruz Polyclinic outpatient Clinic, Municipality of Porto Velho, RO. Brazilian Journal of Development, 2022; 8(11): 74474–74489.
ROSE NR. Prediction and Prevention of Autoimmune Disease in the 21st Century: A Review and Pre-view. Am J Epidemiol. 2016; 183(5): 403-6.
SAMPAIO-BARROS PD, et al. Consenso Brasileiro de Espondiloartropatias: outras espondiloartropati-as diagnóstico e tratamento - primeira revisão. Rev Bras Reumatol. 2007; 47(4): 243–50.
SAMPAIO-BARROS PD, et al. Recomendações sobre diagnóstico e tratamento da esclerose sistêmica. Rev Bras Reumatol. 2013; 53(3): 258–75.
SCHUR P e HAHN BH. Epidemiology and pathogenesis of systemic lupus erythematosus. In: DS Pi-setsky & MR Curtis (Ed), UpToDate, 2021.
SHARIP A e KUNZ J. Understanding the Pathogenesis of Spondyloarthritis. Biomolecules. 2020; 10(10): 1461.
SMITH JUDITH A. Update on ankylosing spondylitis: current concepts in pathogenesis. Curr Allergy Asthma Rep. 2015; 15(1): 489.
SMITS RM, et al. Pharmacological conditioning for juvenile idiopathic arthritis: a potential solution to reduce methotrexate intolerance. Pediatr Rheumatol.2020; 18(12).
TOLENTINO JÚNIOR DILCEU SILVEIRA. Estudo da prevalência de doenças autoimunes na microrregião de saúde de Águas Formosas - Minas Gerais - Brasil. Dissertação (Mestrado Profissional) – Programa de Pós-Graduação em Tecnologia, Ambiente e Sociedade, Universidade Federal dos Vales do Jequiti-nhonha e Mucuri, Teófilo Otoni, 2017; 186.
WALTON C, et al. Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition. Mult Scler. 2020; 26(14): 1816-1821.